SYMDEKO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 25 Oct 2023)
What this means for you
Registered since 10 Apr 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87184433
- Registration number
- 5444185
- Mark type
- Stylized text
- Filed
- 27 Sept 2016
- Published for opposition
- 07 Feb 2017
- Registered
- 10 Apr 2018
- Attorney of record
- Kelli A. Ovies
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cystic fibrosis
Owner
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
Prosecution history
- 25 Oct 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 25 Oct 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 25 Oct 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Apr 2023 — TEAS SECTION 8 & 15 RECEIVED
- 10 Apr 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Apr 2018 — REGISTERED-PRINCIPAL REGISTER
- 07 Mar 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Mar 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Mar 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Feb 2018 — USE AMENDMENT FILED
- 06 Mar 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Feb 2018 — TEAS STATEMENT OF USE RECEIVED
- 05 Oct 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Oct 2017 — SOU EXTENSION 1 GRANTED
- 03 Oct 2017 — SOU EXTENSION 1 FILED